drugset / Trial / NCT01121289
A Trial Investigating NN1218 in Subjects With Type 1 Diabetes
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the absorption and effect in the body of NN1218 in subjects with type 1 diabetes.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin aspart | Protein / enzyme biologic | 0.2 iu/kg | Subcutaneous |
| Comparator | insulin aspart | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |